NVIDIA (NVDA) Poised for Strong Q1 2025 Earnings Lift

Author's Avatar
Apr 09, 2025
Article's Main Image
  • NVIDIA (NVDA, Financial) anticipates a substantial Q1 2025 performance, with significant earnings growth.
  • Analysts predict a notable upside in NVIDIA's stock price, bolstered by its Data Center segment.
  • Current evaluations mark NVIDIA as an "Outperform" investment opportunity.

NVIDIA Corp. (NVDA) is gearing up for its Q1 2025 earnings release on May 28, capturing the attention of investors with expectations of a 52% boost in EPS and a 65% increase in sales. This optimism is primarily driven by robust demand and exceptional expansion in NVIDIA's Data Center segment.

Wall Street's Outlook on NVIDIA

1910016447300661248.png

Top financial analysts have weighed in with their projections for NVIDIA, setting a one-year average price target of $171.46. These targets range from a high of $235.92 to a low of $120.00, presenting an average upside potential of 70.90% from the current trading price of $100.32. For additional insights, visit the NVIDIA Corp (NVDA, Financial) Forecast page.

The consensus recommendation, derived from the insights of 63 brokerage firms, places NVIDIA at an average rating of 1.7, which denotes an "Outperform" status. This recommendation scale operates from 1 to 5, with 1 indicating a "Strong Buy" and 5 indicating a "Sell".

NVIDIA's GF Value Projection

According to GuruFocus estimates, NVIDIA’s GF Value for the coming year stands at $265.65. This suggests a remarkable potential upside of 164.79% from its current price of $100.3243. The GF Value represents GuruFocus's assessment of the stock's fair trading value, calculated through historical trading multiples and the company's historical and projected business growth. More comprehensive details can be accessed on the NVIDIA Corp (NVDA, Financial) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.